May Bulletin
Issue 56
Community Notices | News | Jobs | Funding | Events
Community Notices
May seminar
This month's Marble Center seminar is on Monday May 17th (11am-noon, via Zoom) with a research update by Dr. Nick Lamson of the Hammond Lab. The title of the talk is “Noncovalent Functionalization of Layer-by-Layer Nanoparticles with BBB and Tumor Dual Targeting Peptides for Drug Delivery to Glioblastoma.” Following the research update, we will host a hot topic presentation by Calvin Chin, Managing Partner at the MIT E14 Fund.
2021 MIT Postdoctoral Association Mentoring program
The program will run from May to November 2021 and will consist of monthly informal sessions with outstanding mentors who are excited to help the MIT postdoctoral community. They will share their valuable professional insights and experiences, thus providing important information and guidance for your career development. You can access the application page here. Deadline for applications is May 14th.
Marble Center April Distinguished Seminar
Missed our seminar last month with Prof. Joe DeSimone (Stanford University)? You can now find it on our multimedia page.
Mark your calendar! Annual reports due in June
Annual reports for Marble Center projects will be due on June 11th. Next academic year’s RFP will be issued early July. If you have any questions, please contact Tarek Fadel (tfadel@mit.edu).
In the News
Dr. Paula Hammond named Institute Professor
Two distinguished MIT chemical engineers, Drs. Paula Hammond and Arup K. Chakraborty, have been named Institute Professors, the highest honor bestowed upon MIT faculty members.
Dr. Paula Hammond, who chairs MIT’s Department of Chemical Engineering and is a member of the Koch Institute for Integrative Cancer Research (KI) and the KI’s Marble Center for Cancer Nanomedicine faculty, is renowned for her work in developing novel polymers and nanomaterials. The appointment will take effect July 1, 2021. Read more…
The NCI Nanotechnology Characterization Laboratory annual report
The NCL has just published its 2020 Annual Report. The report highlights NCL's research activities in support of the program's four objectives: characterize nanomedicines using standardized methods, conduct structure activity relationship (SAR) studies, facilitate regulatory review of nanotech constructs, and engage in educational and knowledge sharing efforts.
In addition, the report highlights keys metrics including acceptance rates for application to NCL's Assay Cascade characterization program, number of nanoparticles characterized, protocols made available to the public and more.
Opening the path to biotech
Drs. Sangeeta Bhatia, Nancy Hopkins, and Susan Hockfield share their thoughts on addressing the gender imbalance in biotech in a recent editorial of Science Magazine. Read more…
Jobs
Senior Scientist – Center for Biological Innovation.
The Center for Biological Innovation (CBI) is a Boston Scientific Corp. Center of Excellence that utilizes in vitro and ex vivo approaches, such as biochemical, cell-based, microbial, and tissue-based assays to support the design, development and commercialization of BSC products. The successful Scientist candidate should have appropriate scientific experience to provide the technical support required for planning, conduct, analysis, and reporting of in vitro biomedical research studies. Read More…
Research Scientist, Spark Therapeutics.
The Research Scientist – Medicinal Chemistry is a member of the Discovery Research Group within the Research Department and will support laboratory research activities towards the development and testing of non-viral gene therapy products. He/she will be responsible for: developing and executing synthetic strategies towards different modalities, such as lipidoids, small-molecule drug conjugates; implementing different analytical methods, including but not limited to, chromatography, mass spectrometry, NMR, to support the development of non-viral gene delivery platforms; initiating and managing collaborations with external parties; collaborating with other Translational Research Scientists to design in vitro and in vivo experiments to optimize development candidates; and writing study reports, documents to support regulatory filings, manuscripts, and present results at appropriate scientific meetings. Read More…
Biomedical engineer, GelMEDIX, Inc.
GelMEDIX is looking to recruit a Biomedical Engineer/Bioengineer to join the R&D team and support the development of novel ocular products. GelMEDIX’s proprietary platforms allow for great breadth and opportunity in various disease areas, and the candidate may work on multiple programs in parallel at various stages of development. The candidate will have strong, hands-on, bench-oriented laboratory experience in biomaterial/hydrogel synthesis, prototype development, and drug delivery. S/he will be comfortable working independently in a fast-paced environment, thinking broadly and innovatively beyond his/her own discipline. This is a unique opportunity to be an important early contributor to the success of a well-positioned, exciting and entrepreneurial biopharmaceutical/biomaterial company. Read more…
Funding opportunities
| Funding Source | Grant ID | Deadline |
|---|---|---|
| Cancer Research Program (PRCRP) Impact award (pre-proposals) | W81XWH-21 | August 18, 2021 |
| NIH/NCI: Toward Translation of Nanotechnology Cancer Interventions | PAR-20-116 | November 18, 2021 |
